Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emil Lou

Showing results (81-90 of 184) with videos related to

Pageof 19
Sort By:
Annals of Surgical Oncology|July 18, 2019
Completion of Adjuvant Chemotherapy After Upfront Surgical Resection for Pancreatic Cancer Is Uncommon Yet Associated With Improved SurvivalAriella M Altman, Keith Wirth, Schelomo Marmor, et al.
Medrxiv : the Preprint Server for Health Sciences|June 27, 2020
Emotional health concerns of oncology physicians in the United States: fallout during the COVID-19 pandemicLauren Thomaier, Deanna Teoh, Patricia Jewett, et al.
Oncotarget|May 26, 2016
Tunneling nanotube formation is stimulated by hypoxia in ovarian cancer cellsSnider Desir, Elizabeth L Dickson, Rachel I Vogel, et al.
The Oncologist|January 6, 2026
Age- and Sex-Based Differences in the Genomic Profiles of Patients with Gastrointestinal and Pancreatic Neuroendocrine NeoplasmsShuning Li, Lisa Liu, Nishant Gandhi, et al.
Surgical Oncology|September 6, 2020
The addition of chemoradiation to adjuvant chemotherapy is associated with improved survival in lymph node-positive gastric cancerAriella M Altman, Adam C Sheka, Schelomo Marmor, et al.
Laboratory Medicine|January 24, 2018
Assessment of Circulating Tumor Cells as a Predictive Biomarker of Histology in Women With Suspected Ovarian CancerEmil Lou, Rachel I Vogel, Deanna Teoh, et al.
Molecular Biology of the Cell|January 5, 2022
Quantitative biophysical metrics for rapid evaluation of ovarian cancer metastatic potentialApratim Mukherjee, Haonan Zhang, Katherine Ladner, et al.
Cancer Research|July 15, 2022
The Mechanisms of Action of Tumor Treating FieldsJustin C Moser, Ellaine Salvador, Karina Deniz, et al.
The Oncologist|May 31, 2015
Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable GlioblastomaKatherine B Peters, Emil Lou, Annick Desjardins, et al.
Cancers|November 13, 2025
Molecular Characterization of Polyomavirus-Positive and Negative Merkel Cell CarcinomaPoorva Vaidya, Sharon Wu, Dave Bryant, et al.
Pageof 19

Showing results (81-90 of 184) with videos related to

Sort By:
Pageof 19
Annals of Surgical Oncology|July 18, 2019
Completion of Adjuvant Chemotherapy After Upfront Surgical Resection for Pancreatic Cancer Is Uncommon Yet Associated With Improved SurvivalAriella M Altman, Keith Wirth, Schelomo Marmor, et al.
Medrxiv : the Preprint Server for Health Sciences|June 27, 2020
Emotional health concerns of oncology physicians in the United States: fallout during the COVID-19 pandemicLauren Thomaier, Deanna Teoh, Patricia Jewett, et al.
Oncotarget|May 26, 2016
Tunneling nanotube formation is stimulated by hypoxia in ovarian cancer cellsSnider Desir, Elizabeth L Dickson, Rachel I Vogel, et al.
The Oncologist|January 6, 2026
Age- and Sex-Based Differences in the Genomic Profiles of Patients with Gastrointestinal and Pancreatic Neuroendocrine NeoplasmsShuning Li, Lisa Liu, Nishant Gandhi, et al.
Surgical Oncology|September 6, 2020
The addition of chemoradiation to adjuvant chemotherapy is associated with improved survival in lymph node-positive gastric cancerAriella M Altman, Adam C Sheka, Schelomo Marmor, et al.
Laboratory Medicine|January 24, 2018
Assessment of Circulating Tumor Cells as a Predictive Biomarker of Histology in Women With Suspected Ovarian CancerEmil Lou, Rachel I Vogel, Deanna Teoh, et al.
Molecular Biology of the Cell|January 5, 2022
Quantitative biophysical metrics for rapid evaluation of ovarian cancer metastatic potentialApratim Mukherjee, Haonan Zhang, Katherine Ladner, et al.
Cancer Research|July 15, 2022
The Mechanisms of Action of Tumor Treating FieldsJustin C Moser, Ellaine Salvador, Karina Deniz, et al.
The Oncologist|May 31, 2015
Phase II Trial of Upfront Bevacizumab, Irinotecan, and Temozolomide for Unresectable GlioblastomaKatherine B Peters, Emil Lou, Annick Desjardins, et al.
Cancers|November 13, 2025
Molecular Characterization of Polyomavirus-Positive and Negative Merkel Cell CarcinomaPoorva Vaidya, Sharon Wu, Dave Bryant, et al.
Pageof 19